# GREFFEX INC: Form D filing

GREFFEX INC, a biotechnology company in Aurora, CO, filed a Form D with the SEC in 2017. The latest, on August 11, 2017, reports $155,000 sold of a $20 million offering to 2 investors.

Find out what GREFFEX INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20GREFFEX%20INC%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=GREFFEX%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Fgreffex-inc-1439539)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20GREFFEX%20INC%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=GREFFEX%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Fgreffex-inc-1439539)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Colorado](https://specstream.ai/data/form-d/state/colorado): 1,787 rows, by operating companies, filed since November 1, 2024, $89.35, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/colorado
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 12635 E. MONTVIEW BLVD., SUITE 308, Aurora, CO, 80045
- Phone: (866) 723-4884
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1439539

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Aug 11, 2017 | New notice | $20,000,000 | $155,000 | $19,845,000 | 2 | Jul 28, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1439539/000143953917000003/0001439539-17-000003-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Sir Walter S. Bodmer | Director |  |
| Jehan S. Al-Meer | Director |  |
| John R. Price | Executive Officer, Director |  |
| Phillip S. Zobrist | Director |  |
| William S. Connolly | Executive Officer, Director |  |
| Uwe D. Staerz | Executive Officer, Director |  |

## Other biotechnology companies in Colorado that filed recently

- [HealthVest Fund V LLC](https://specstream.ai/data/form-d/company/healthvest-fund-v-llc-2163605) offering · Nov 5, 2026
- [GelSana Therapeutics, Inc.](https://specstream.ai/data/form-d/company/gelsana-therapeutics-inc-2002665) $4.4 million · Oct 8, 2026
- [Renovare Therapeutics, Inc.](https://specstream.ai/data/form-d/company/renovare-therapeutics-inc-2158361) $100,000 · Oct 2, 2026
- [EnteroTrack, LLC](https://specstream.ai/data/form-d/company/enterotrack-llc-1612812) $2 million · Sep 25, 2026

[Every Form D from the week of Aug 7, 2017](https://specstream.ai/data/form-d/week/2017-08-07) · [All recent filings in Colorado](https://specstream.ai/data/form-d/state/colorado) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what GREFFEX INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).